Columbia Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,200,000
Closed -$1.19M 235
2024
Q4
$1.19M Buy
+1,200,000
New +$356M 0.22% 80

Other funds holding AMGN

Columbia Asset Management's AMGN Position: Q2 2026 in Review

Columbia Asset Management reduced its Amgen (AMGN) stake by 4.3% in Q2 2026, selling an estimated $329K and leaving 21,458 shares worth $7.77M. The position accounts for 1.35% of the portfolio, ranked #20.

Columbia Asset Management first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.89M in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Columbia Asset Management held 21,458 shares of Amgen worth $7.77M as of Q2 2026.
  • Columbia Asset Management sold 962 Amgen shares in Q2 2026, an estimated $329K.
  • Amgen made up 1.35% of Columbia Asset Management's portfolio in Q2 2026, its #20 holding.
  • Columbia Asset Management first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
  • Columbia Asset Management's Amgen position peaked at $7.89M in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.